In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

Innovators wanting to market their products must first review the existing HA regulatory framework for medical devices to determine the correct pathway. The first step is to assess whether or not ...

The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...

Medical technology company Stryker (NYSE:SYK) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales ...

Centres of Excellence for Regulatory Science and Innovation (CERSIs) to help drive advancements in healthcare.Pioneering use of artificial intelligence (AI) could cut the time it takes to bring ...

Life sciences company Neogen (NASDAQ:NEOG) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on ...

Key highlights included in-depth discussions on regulatory updates and challenges specific to the MEA region, networking ...

Abhishek Pandurang Benke led the development of an innovative cardiovascular diagnostic device, improving accuracy, speed, ...

The University of Liverpool will lead on a project which explores the potential of pharmacogenomics – the study of how the variation of the human genome affects the efficacy and safety of medicines – ...

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

The University of Liverpool will lead on a project which explores the potential of pharmacogenomics - the study of how the variation of the human ...